FY2024 EPS Estimates for Addus HomeCare Increased by KeyCorp

Addus HomeCare Co. (NASDAQ:ADUS - Free Report) - Equities research analysts at KeyCorp increased their FY2024 earnings estimates for shares of Addus HomeCare in a report released on Monday, January 6th. KeyCorp analyst M. Gillmor now forecasts that the company will post earnings of $4.52 per share for the year, up from their prior estimate of $4.50. KeyCorp currently has a "Strong-Buy" rating on the stock. The consensus estimate for Addus HomeCare's current full-year earnings is $4.59 per share. KeyCorp also issued estimates for Addus HomeCare's Q1 2025 earnings at $1.14 EPS, Q2 2025 earnings at $1.31 EPS, Q3 2025 earnings at $1.34 EPS, Q4 2025 earnings at $1.47 EPS and FY2025 earnings at $5.26 EPS.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its earnings results on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.28 by $0.02. The firm had revenue of $289.80 million during the quarter, compared to analyst estimates of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The business's revenue was up 7.1% on a year-over-year basis. During the same period last year, the business earned $1.03 earnings per share.

Several other research analysts have also recently issued reports on ADUS. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $136.00 target price on shares of Addus HomeCare in a report on Thursday, November 14th. StockNews.com raised Addus HomeCare from a "hold" rating to a "buy" rating in a research report on Wednesday, December 11th. Citizens Jmp raised Addus HomeCare to a "strong-buy" rating in a report on Monday, December 16th. JMP Securities started coverage on Addus HomeCare in a report on Monday, December 16th. They set an "outperform" rating and a $150.00 price target on the stock. Finally, Stephens lifted their price objective on Addus HomeCare from $143.00 to $145.00 and gave the stock an "overweight" rating in a report on Wednesday, November 6th. One research analyst has rated the stock with a sell rating, nine have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Buy" and a consensus target price of $133.67.

Addus HomeCare Stock Performance

Shares of ADUS traded up $0.72 during trading hours on Thursday, hitting $126.42. The company had a trading volume of 109,891 shares, compared to its average volume of 138,318. Addus HomeCare has a 52-week low of $85.94 and a 52-week high of $136.12. The firm has a fifty day moving average price of $125.04 and a 200-day moving average price of $125.95. The stock has a market capitalization of $2.29 billion, a price-to-earnings ratio of 28.93, a P/E/G ratio of 2.11 and a beta of 1.00.

Institutional Investors Weigh In On Addus HomeCare

A number of institutional investors have recently added to or reduced their stakes in the stock. Point72 Asset Management L.P. grew its stake in Addus HomeCare by 73.4% during the second quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company's stock valued at $86,598,000 after acquiring an additional 315,602 shares in the last quarter. Millennium Management LLC grew its position in shares of Addus HomeCare by 412.7% during the second quarter. Millennium Management LLC now owns 316,418 shares of the company's stock valued at $36,739,000 after purchasing an additional 254,705 shares in the last quarter. Wasatch Advisors LP increased its holdings in shares of Addus HomeCare by 11.8% in the third quarter. Wasatch Advisors LP now owns 1,043,240 shares of the company's stock worth $138,782,000 after purchasing an additional 110,010 shares during the last quarter. Ghisallo Capital Management LLC purchased a new stake in shares of Addus HomeCare in the second quarter worth about $11,611,000. Finally, Principal Financial Group Inc. boosted its stake in Addus HomeCare by 17.5% during the third quarter. Principal Financial Group Inc. now owns 505,853 shares of the company's stock valued at $67,293,000 after buying an additional 75,409 shares during the last quarter. 95.35% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Addus HomeCare

In other Addus HomeCare news, EVP Roberton James Stevenson sold 2,250 shares of the stock in a transaction on Monday, December 9th. The stock was sold at an average price of $121.00, for a total value of $272,250.00. Following the completion of the sale, the executive vice president now owns 10,217 shares in the company, valued at approximately $1,236,257. This represents a 18.05 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO R Dirk Allison sold 12,500 shares of the business's stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $123.16, for a total value of $1,539,500.00. Following the completion of the transaction, the chief executive officer now owns 141,897 shares in the company, valued at $17,476,034.52. The trade was a 8.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 39,750 shares of company stock valued at $4,930,750. Insiders own 4.60% of the company's stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.